Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Ortiz-Alcantara J
    • Other Affiliation: Texas A&M University
  • Bhardwaj K
    • Other Affiliation: Indiana University, Bloomington
  • Palaninathan S
    • Other Affiliation: Texas A&M University
  • Frieman M
    • Affiliation: Gillings School of Global Public Health, Department of Epidemiology
  • Baric R
    • Affiliation: Gillings School of Global Public Health, Department of Epidemiology
  • Kao C
    • Other Affiliation: Indiana University, Bloomington
Abstract
  • The severe acute respiratory syndrome (SARS) virus encodes several unusual RNA processing enzymes, including Nsp15, an endoribonuclease that preferentially cleaves 3’ of uridylates through a ribonuclease A (RNase A)-like mechanism. Crystal structures of Nsp15 confirmed that the Nsp15 active site is structurally similar to that of RNase A. These similarities and our molecular docking analysis lead us to hypothesize that previously characterized RNase A inhibitors will also inhibit the SARS-CoV Nsp15. Benzopurpurin B, C-467929, C-473872, N-306711, N-65828, N-103019 and congo red were tested for effects on Nsp15 endoribonuclease activity. A fluorescence assay revealed that the IC50 values for inhibiting endoribonuclease activity were between 0.2 µM and 40 µM. These compounds were demonstrated to bind SARS-CoV Nsp15 by a differential scanning fluorimetry assay. Benzopurpurin B also inhibited the endoribonuclease activities of the Nsp15 orthologs from two other coronaviruses: mouse hepatitis virus (MHV) and infectious bronchitis virus (IBV). Benzopurpurin B, C-473872, and congo red reduced infectivity of MHV in L2 cells by 8- to 26- fold. The more effective drugs caused a decrease in MHV RNA accumulation. All three compounds reduced the infectivity of the SARS-CoV in Vero cells.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
License
  • Attribution-NonCommercial 3.0 United States
Journal title
  • Virus Adaptation and Treatment
Journal volume
  • 2
Journal issue
  • 1
Page start
  • 125
Page end
  • 133
Language
  • English
ISSN
  • 1179-1624

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details VAAT-12733-small-molecule-inhibitors-of-the-sars-cov-nsp15-endoribonucl_090310.pdf 2020-03-26 Public Download